IAXO-101 iodide
IAXO-101 iodide is a TLR4/CD14 blocker. IAXO-101 iodide can inhibit the innate immune pathway of CD14. IAXO-101 iodide is capable of improving the recording performance of intracortical microelectrodes in mice. IAXO-101 iodide can also partially alleviate fetal growth restriction, placental vascular damage, and reduce the level of the inflammatory factor TNF-α in pregnant mice infected with malaria. IAXO-101 iodide can be used in the research of gestational malaria and inflammatory diseases.
For research use only. We do not sell to patients.
- CAS No.: 1202388-64-4
- Formula: C42H84INO5
- Molecular Weight:810.02
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
|
TLR4 |
Chemical Information
-
CAS No. 1202388-64-4
-
Molecular Weight 810.02
-
Formula C42H84INO5
-
SMILES
CCCCCCCCCCCCCCO[C@@H]1[C@H]([C@@H]([C@@H](C[N+](C)(C2CCCC2)C)O[C@@H]1OC)O)OCCCCCCCCCCCCCC.[I-]
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
References
[1]. Hermann JK, et al. Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance. J Neural Eng. 2018 Apr;15(2):025002. [Content Brief]
[2]. Barboza R, et al. TLR4-Mediated Placental Pathology and Pregnancy Outcome in Experimental Malaria. Sci Rep. 2017 Aug 17;7(1):8623. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)